Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Strengths include clarity and control, while weaknesses may involve complexity and time to maintain across life changes.
28,655 articlesWhen a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
A notable stake reduction by pacific ridge capital trims its NWPX position, signaling a shift in exposure. This guide...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
Investors are flocking to energy’s hottest trade: high-yielding integrateds and midstream giants. Fresh cash-flow dat...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A single Tuesday remark from a prominent political figure can ripple through the markets. This article explains what ...
This week, plug power stock rocketed about 20% as earnings and feasibility signals fed optimism about hydrogen adopti...
A no-action relief granted to Phantom allows crypto wallets to function as consumer interfaces for regulated derivati...
When a top Remitly executive sells shares, investors want to know what it means. This guide explains insider sales, h...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...